Results 191 to 200 of about 39,695 (260)

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

open access: yesBMEMat, EarlyView.
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao   +4 more
wiley   +1 more source

Indirect effect and pneumococcal conjugate vaccines

open access: yesПедиатрическая фармакология, 2009
L. Temimi
doaj   +2 more sources

Safety and Immunogenicity of SII's 10-Valent Pneumococcal Conjugate Vaccine (PCV10-SII) in Vietnamese Children Aged from 6 Weeks to 24 Months: An Open-Label, Single-Arm Bridging Study. [PDF]

open access: yesVaccines (Basel)
Son VT   +14 more
europepmc   +1 more source

Evaluation of rotavirus, pneumococcal conjugate and human papillomavirus vaccination in four Pacific island countries: A cost-effectiveness modelling study. [PDF]

open access: yesPLoS Med
Carvalho N   +14 more
europepmc   +1 more source

Aluminium adjuvants in vaccines and potential health effects: systematic review.

open access: yesBMJ
Doyon-Plourde P   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy